Summit Trail Advisors, LLC Novo Cure LTD Transaction History
Summit Trail Advisors, LLC
- $3 Billion
- Q1 2025
A detailed history of Summit Trail Advisors, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 55,598 shares of NVCR stock, worth $1.02 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
55,598
Previous 15,028
269.96%
Holding current value
$1.02 Million
Previous $447,000
121.48%
% of portfolio
0.03%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding NVCR
# of Institutions
295Shares Held
75.8MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$222 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$216 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$162 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$88.2 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$50.2 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.92B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...